Concepedia

Joel Gatlin

JG

Statistics

Publications

17

Citations

1.4K

H-Index

15

Active since

1995

Affiliations

Arena Pharmaceuticals (United States)(Current)

The University of Texas Southwestern Medical Center

Beacon Clinical Research

St. Jude Children's Research Hospital

Joel Gatlin is an author at Arena Pharmaceuticals (United States) specializing in life sciences, pharmacology, and molecular biology.

Publications per year

1995–2018

17

Publications

17

Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1

Michael W. Melkus, Jacob D. Estes, Angela Padgett‐Thomas et al. · Nature Medicine · 2006 · 648 citations

, , +14

Production of transgenic rats by lentiviral transduction of male germ-line stem cells

F. Kent Hamra, Joel Gatlin, Karen Chapman et al. · Proceedings of the National Academy of Sciences · 2002 · 242 citations · Full text

, , +12

Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor

Daniel J. Buzard, Sun Hee Kim, Luis Lopez et al. · ACS Medicinal Chemistry Letters · 2014 · 72 citations · Full text

, , +17

Angiotensin (1–7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor

Ibragim Gaidarov, John W. Adams, John Frazer et al. · Cellular Signalling · 2018 · 60 citations

, , +7

Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors

A. Karolina Palucka, Joel Gatlin, Jean Philippe Blanck et al. · Blood · 2003 · 59 citations · Full text

, , +11

1–5 of 17